Alpha Genesis Expands GLP Capacity Following Multi-Million-Dollar Investment to Accelerate IND-Enabling Nonhuman Primate Studies

October 14, 2025 9:00 AM

Alpha Genesis, Inc. (AGI), one of the United States' largest nonhuman primate research and breeding organizations, today announced a significant expansion of its Good Laboratory Practice (GLP) program following more than $3 million in new infrastructure and personnel investments. The expansion builds on several years of successful GLP operations and was undertaken to meet increasing client demand for IND-enabling toxicology and pharmacokinetic...

Read more

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

October 14, 2025 8:50 AM

Sunshine Biopharma (NASDAQ:SBFM) is the kind of company that keeps the market honest. On paper, it's small, barely a rounding error next to the giants of biotech. But size isn't the story here. Execution is. Sunshine has spent the past year building an engine that's starting to hum across multiple fronts: generics, biosimilars, mRNA cancer therapies, and antiviral research. And in the process, it's doing what small companies rarely do well:...

Read more

Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025

October 14, 2025 8:45 AM

Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathic disorders, today announces that Greg Duncan, Chief Executive Officer will participate at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 - 23, 2025 at the Hard Rock Hotel in New York City.Mr. Duncan will be available for one-on-one meetings with...

Read more

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

October 14, 2025 8:30 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products based on its patented Microcyn® technology, today announced the launch of a new HOCl wound cleanser manufactured by Sonoma for Medline Industries, LP. The product will be distributed by Medline into hospital systems, home healthcare and other healthcare channels across the United States.The collaboration...

Read more

Leni Alston Advocates for Clearer, Kinder Healthcare Support

October 14, 2025 8:20 AM

In a newly released feature, respected healthcare marketing professional Leni Alston is speaking out about the need for more compassion and clarity in the healthcare industry - especially for families navigating care options. Drawing from years of frontline experience, Alston is urging healthcare workers, professionals, and everyday citizens to take simple, direct steps to help those around them feel seen, heard, and supported."Families aren't...

Read more

Healthcare Triangle's Strategic Intent Rewarded with a 32% Share Gain Since September (NASDAQ:HCTI)

October 14, 2025 8:15 AM

The market always appreciates a great company story. The problem is that it often rewards the ones that sound big, not necessarily the ones that are big. Healthcare Triangle Inc. (NASDAQ:HCTI) has decided to flip that script. It's no longer selling a dream; it's selling proof. And in a smallcap world drowning in hypotheticals, proof is the rarest currency there is.In the span of a few weeks, HCTI has managed to play both sides of the smallcap...

Read more

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

October 14, 2025 8:00 AM

Entero Therapeutics (NASDAQ:ENTO) didn't tiptoe into reinvention. It jumped. The company, once known for enzymes and patient trials, is now in the grid game, acquiring GRID AI in a deal that rewires its entire identity. That may sound dramatic, but reinvention usually is. Investors who only saw a challenged biotech woke up to find the ticker transformed into a player in one of the most valuable races of the decade: making sure the power keeps...

Read more

2026 Top Health Information Management Systems Vendors

October 14, 2025 8:00 AM

Black Book Research today announced the results of its 2026 Health Information Management (HIM) Top Vendors Awards, following a comprehensive, independent polling initiative conducted from February 1 through October 1, 2025. The extensive study gathered responses from 8,237 verified participants, representing 3,220 provider organizations: including hospitals, ambulatory care centers, and physician groups, and 251 payer and value-based care (VBC)...

Read more

Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer

October 14, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced new laboratory findings demonstrating that Telomir-1 kills aggressive pancreatic cancer cells.Study SummaryIn laboratory studies using human pancreatic cancer (PANC-1) cells, Telomir-1 produced a concentration-dependent...

Read more

Every Word Matters: The Next Chapter of Our Universal Patient Language

October 14, 2025 7:00 AM

At Bristol Myers Squibb (BMS), we believe that how we communicate can be just as important as what we're communicating - especially when it comes to people's health.Patients often encounter a flood of information along their medical care journey - some of it helpful, much of it overwhelming. Whether they're reading an educational article online, flipping through a brochure in a waiting room or navigating an informed consent form with their...

Read more

CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division

October 14, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, proudly announces a major order from Smoking Scholars Dispensary, located at 784 Allerton Avenue, Bronx, NY 10467, marking a powerful expansion milestone in the company's rapidly growing beverage division.Smoking Scholars, a premier dispensary serving thousands of customers across the Bronx and greater New York City area, has officially placed a large-scale order of CBDL's...

Read more

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

October 14, 2025 7:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced its Board of Directors has formally approved a strategic investment of $5 million in Bitcoin (BTC) as a strategic reserve asset. This move aligns with Sunshine Biopharma's broader strategy to strengthen its financial foundation...

Read more

CLn Skin Care Appoints Dr. Amir Moradi to Medical Advisory Board

October 14, 2025 7:00 AM

CLn Skin Care, a leading provider of dermatologist-developed therapeutic skincare, is proud to announce that Dr. Amir Moradi, MD, has joined its Medical Advisory Board. A respected authority in aesthetic and reconstructive facial plastic surgery, Dr. Moradi brings over 20 years of clinical and research expertise to the CLn team.As a member of the advisory board, Dr. Moradi will support CLn Skin Care's mission to advance science-driven skincare...

Read more

Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union

October 14, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that it has entered into an expanded distribution agreement with Grovet b.v., a leading equine health company based in the Netherlands. The amended agreement expands Grovet's existing distribution rights for equine therapeutic devices by...

Read more

Visible Tumor Uptake and Recommended Dose Increase in Spago Nanomedicals's Phase I/IIa Study Tumorad-01

October 14, 2025 5:50 AM

Spago Nanomedical AB (publ) (STO:SPAGO.ST)(FRA:7UX.F) announced today that the independent Data Monitoring Committee (DMC) recommends a dose increase in the ongoing Phase I/IIa clinical trial Tumorad-01 with the radiopharmaceutical drug candidate 177Lu-SN201. In addition, significant visible tumor uptake of 177Lu-SN201 has been observed on SPECT images, which can be considered a proof-of-concept for Tumorad in humans according to the DMC. This...

Read more

Middle East & Africa Health Systems Pivot Toward openEHR to Escape Legacy Middleware Trap

October 14, 2025 5:00 AM

Black Book Research today released new findings from a 2026 Middle East and Africa Interoperability Options Survey, revealing that healthcare leaders in 18 countries are actively piloting or discussing openEHR architectures as sustainable alternatives to legacy middleware, interface engines, and proprietary interoperability tools.The independent survey conducted in Q3 gathered insights from 210 health system, hospital, ministry, and agency...

Read more

AGFA HealthCare Powers Enterprise Imaging Modernization Across North America

October 14, 2025 4:00 AM

AGFA HealthCare is accelerating the transformation of Enterprise Imaging across the U.S. and Canada, enabling hospitals, health networks, and government organizations to modernize and unify their imaging infrastructure with speed, confidence, security, and scale. In the second quarter of 2025, AGFA HealthCare delivered several high-impact go-lives, in the cloud and on customers' premises , and system expansions across Radiology, Cardiology, and...

Read more

Response Letter to Previous Article Published about Alzstatin's Unique Mode of Action Against Alzheimer's

October 14, 2025 2:15 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that a response letter has been published related to the previously published scientific article on Alzstatin and the lead drug candidate in the project, ACD680.The response letter, titled Response to the Letter to the Editor on...

Read more

Altior Healthcare's CFO, Jonathan Monroe, Recognized by the Los Angeles Business Journal for Turnaround Achievement

October 13, 2025 5:00 PM

Altior Healthcare, a national network of specialized mental health treatment programs, is proud to announce that Chief Financial Officer Jonathan Monroe, C.P.A., has been recognized by the Los Angeles Business Journal as a nominee for the CFO of the Year Awards in the Turnaround Achievement Category. The annual awards honor outstanding financial executives whose strategic leadership and fiscal stewardship have strengthened their organizations...

Read more

Healthcare Triangle Plays Offense to Redefine What Aggressive Growth Looks Like (NASDAQ: HCTI)

October 13, 2025 3:00 PM

Healthcare Triangle Inc. (NASDAQ:HCTI) published a recent press release that included a headline that could've been mistaken for corporate filler- "executes aggressive growth." But this one hits different. What sounds routine is actually a signal. With a market cap of just $16 million, Healthcare Triangle is proving that size isn't strategy.While most small caps tread lightly, HCTI is accelerating - signing LOIs, launching AI platforms, and...

Read more